GFS202A

GFS202A · Genfleet Therapeutics (Shanghai) Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GFS202A, covering 2025-06-05 to 2025-06-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia [Phase 1]